10Auditory neuropathy & OTOF

TThe paradox of auditory neuropathy

Auditory neuropathy spectrum disorder (ANSD) is defined by a contradiction on testing: otoacoustic emissions are present (the outer hair cells work) but the auditory brainstem response is absent or grossly abnormal (neural transmission is disordered). Hearing is present but dyssynchronous — sound is detected yet poorly understood. On the face of it, restoring input to a pathway that cannot transmit it cleanly seems unpromising.

CIt depends on the site

ANSD is not one disease but a heterogeneous groupdefined by where along the inner-hair-cell-to-nerve path the dyssynchrony arises. The implant's usefulness depends entirely on that site, exactly as the spiral-ganglion hypothesis predicts. A lesion before the spiral-ganglion neurons — at the synapse — is bypassed by the electrode; a lesion in the nerve or ganglion is not.

COTOF — the pre-neural lesion

The single commonest cause of ANSD — roughly half of cases — is mutation of OTOF, encoding otoferlin, the protein that triggers transmitter release at the inner-hair-cell ribbon synapse. The defect is therefore pre-neural: the inner hair cell cannot signal to a perfectly healthy nerve. Such children often pass an OAE-based newborn screen (outer hair cells intact) yet have absent ABRs. Because the lesion sits before the spiral ganglion, a cochlear implant bypasses it cleanly — and OTOF recipients are good performers.[2006]

FTWhy screening matters here

ANSD is also why newborn screening of high-risk infants must use automated ABR, not OAE alone (Chapter 5): an OAE-only screen passes the very babies — OTOF and other ANSD — whose hearing is most disordered. Catching them requires a test of the neural pathway, and catching them early matters, because for the OTOF group an implant offers an excellent result if provided in time.

CImplanting auditory neuropathy

The practical message overturns an old pessimism: auditory neuropathy is not a contraindication to implantation. Where the lesion is pre-neural — OTOF above all — outcomes are excellent; where it is truly neural, they are poorer, but even then an implant is often worthwhile. Genetic testing helps stratify: identifying OTOF predicts a good result and supports proceeding with confidence. ANSD is the chapter's cleanest demonstration that site, not the scary label, decides the outcome.[2012]

From outcomes we turn to the people and the principles around them — counselling, recurrence and ethics (Module 11).